diabetestalk.net

Invokana Ketoacidosis Lawsuit

Invokana And Diabetic Ketoacidosis

Invokana And Diabetic Ketoacidosis

For a confidential, no-obligation consultation with our dangerous drug lawyers, use the contact form below, email me at [email protected], or call my office toll-free (844) 459-8719 or locally at (215) 948-2718. We are currently accepting Invokana kidney injury cases, including diabetic ketoacidosis claims. How Invokana Causes Kidney Problems And Diabetic Ketoacidosis For decades, diabetics have treated with metformin or, if that doesnt work, insulin. Recently, however, drug companies have seen diabetes as a potential goldmine, and so have started pushing new types of diabetes drugs, including SGLT2 inhibitors, like Invokana. (Read more about the differences between Invokana, metformin, and Januvia .) Invokana was approved by the FDA as a diabetes treatment in March 2013. Since then, the FDA has issued six safety labeling changes and five drug safety communications.(1) The National Diabetes Education Initiative, too, has said that SGLT2 inhibitors have limited long-term experience, and so are not recommended as an initial treatment.(2) One of the biggest side effects of diabetes is having too much glucose in the bloodstream (hyperglycemia). Invokana works by blocking SGLT2, an enzyme in the kidneys that causes the kidneys to reabsorb glucose. Thus, when a patient takes Invokana, their kidneys process and excrete more glucose, which causes the patient to have lower blood sugar levels, like HbA1c. But any drug that changes the way the kidneys work has the potential to cause kidney injury. Moreover, Invokana does not just inhibit SGLT2, but also inhibits SGLT1, which is found in the kidney, intestines, and brain. Unfortunately, Invokana doesnt just change how the kidneys process glucose. Invokana also causes the blood vessels in the kidneys to contract, and it causes eleva Continue reading >>

Invokana Dka Lawsuit | Diabetic Acidosis Risks | Morgan & Morgan

Invokana Dka Lawsuit | Diabetic Acidosis Risks | Morgan & Morgan

FDA Investigating Injuries Linked to Type 2 Diabetes Medicines In May 2015, the FDA warned that these treatments may put patients at risk for a serious health condition known as ketoacidosis, which may cause diabetic comas or death. In a drug safety announcement , the FDA said it was investigating reports that certain type 2 diabetes drugs caused ketoacidosis. According to the American Diabetes Association , ketoacidosis also known as acidosis or diabetic ketoacidosis (DKA) is a condition that causes the body to produce excessive levels of blood acids, or keytones, leading to the fatal symptoms. The FDAs investigation reportedly came after the agency reviewed 20 adverse event reports from patients who were seriously injured or hospitalized for the condition after taking type 2 diabetes drugs, including Invokana and Invokamet . These drugs belong to a class of medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which have been FDA approved to lower blood sugar in adults with type 2 diabetes. In the FDAs announcement, the agency warned patients that they should seek immediate medical attention if they experience any symptoms of ketoacidosis, including: Continue reading >>

Phoenix Invokana Ketoacidosis Lawyers

Phoenix Invokana Ketoacidosis Lawyers

According to the FDA, these medications have been linked to ketoacidosis, which can lead to a diabetic coma, and kidney failure. Some common signs of ketoacidosis that diabetes patients should be aware of include: If you or someone you love exhibit any of the signs of ketoacidosis, seek medical attention immediately. Between March 2013 and June 2014, the FDA received approximately 20 reports from patients who suffered ketoacidosis or other kidney problems after taking Invokana, Invokamet and other SGLT2s. In May 2015, the FDA publicly issued a drug safety warning announcing their investigation into reports of ketoacidosis, ketosis and diabetic ketoacidosis. All patients who reported these issues were hospitalized or treated in the emergency room. The FDA continued by urging health care professionals and patients to report any side effects involving SGKT2 inhibitors directly to the administration. On May 16, 2017, the FDA added a black box warning to Invokana, Invokamet and Invokamet XR (canagliflozin), citing an increased risk of leg and foot amputations. The FDA found that patients who took Invokana had double the risk of leg and foot amputations as patients who took a placebo. The dangerous drug lawyers at Phillips Law Group are dedicated to fighting for the rights of those who have been injured by a negligent pharmaceutical company. If you or someone you love has suffered from ketoacidosis or other kidney problems are taking Invokana, Invokamet or other SGLT2 inhibitors, we can help you fight for the compensation you deserve. Our lawyers are experienced in handling dangerous drug litigation and have successfully recovered millions in verdicts and settlements on behalf of defective drug victims. Our firm offers free legal consultations and can help you determine your Continue reading >>

Diabetic Ketoacidosis Lawsuit

Diabetic Ketoacidosis Lawsuit

Patients with type-2 diabetes who use new medications in the SGLT2 inhibitor class, such as Invokana, may be at risk of diabetic ketoacidosis. This life-threatening side effect that occurs when toxic acids build up in the blood, and it can cause coma or death without treatment. What You Can Do & How a Lawsuit Can Help The Schmidt Firm, PLLC is currently accepting cases in all 50 states. If you or somebody you know had ketoacidosis after taking a diabetes medication, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753. UPDATE: Invokana Doubles Ketoacidosis Risk, Study Finds In June 2017, a study in the New England Journal of Medicine found that Invokana doubles the risk of diabetic ketoacidosis (DKS) compared to diabetes medications in the DPP-4 inhibitor class. The estimated risk of DKA is 5 to 8 patients per 1,000 who start taking Invokana or other diabetes drugs in the SGLT2 inhibitor class. Click here to read more. Overview Diabetic ketoacidosis, also known as DKA, occurs when toxic acidic waste products known as ketones build up to dangerous levels in the blood and urine. The life-threatening medical emergency occurs when the body starts burning fat as a fuel source instead of using glucose (sugar) in the bloodstream because it does not have enough insulin. When fat cells break down, they release ketones. Serious Complications of Ketoacidosis Cerebral edema (swelling and fluid buildup in the brain) Heart attack Blood clots Extremely low blood pressure Intestinal tissue damage due to lack of blood-flow Kidney failure Coma Death (about 1-5% of cases are deadly) How Is Diabetic Ketoacidosis Treated? Hospitalization is usual Continue reading >>

Injured Patient Files Invokana Ketoacidosis Lawsuit

Injured Patient Files Invokana Ketoacidosis Lawsuit

Injured Patient Files Invokana Ketoacidosis Lawsuit A patient prescribeda diabetes medication that he thought would help him ultimately experienced side effects and filed an Invokana ketoacidosis lawsuit. He and other Invokana patients have come forward with claims of diabetic ketoacidosis and say that they were never warned about the substantial risk of this side effect. Invokana is an SGLT-2 inhibitor that inhibits glucose reabsorption in a patient. This medication is currently approved for use with patients who have type-2 diabetes for the purpose of improving their glycemic control. Unfortunately, however, as alleged in the Invokana ketoacidosis lawsuit , some patients may face a risk of severe side effects that could cause additional pain and medical problems.Diabetic ketoacidosis, for example, may develop after patients have used Invokana for a certain period of time after receiving a prescription from their doctor. Chief among this Invokana lawsuit and other complaints is the development of diabetic ketoacidosis. This condition explains what happens when a persons body turns to burn fat primarily rather than glucose. When the fats are broken down, ketones are put into persons bloodstream. These ketones are extremely acidic. The body typically disposes of excess ketones througha persons urine. Anything causing a persons blood to become too acidic can be dangerous to the patient and could cause dangerous side effects. Diabetic ketoacidosis is usually tied to the presence of two side effects: frequent urination and high glucose levels. If not caught early, this condition could threaten the life of the affected patient. As with other similar lawsuits and claims from patients who have developed this condition, the allegations include that the manufacturers did not pr Continue reading >>

1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations And Heart Complications Now Pending In U.s. Courts, Bernstein Liebhard Llp Reports

1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations And Heart Complications Now Pending In U.s. Courts, Bernstein Liebhard Llp Reports

1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Now Pending in U.S. Courts, Bernstein Liebhard LLP Reports NEW YORK, March 12, 2018 /PRNewswire/ -- Invokana lawsuits filed on behalf of individuals who developed life-threatening complications allegedly related to treatment with the Type 2 diabetes medication continue to mount in courts throughout the United States. According to a February 22nd filing with the U.S. & Securities and Exchange Commission , Johnson & Johnson and its Janssen Pharmaceuticals unit have been named defendants in approximately 1,100 product liability claims involving Invokana, including hundreds of federally-filed cases that have been centralized in the U.S. District Court, District of New Jersey. Hundreds of additional Invokana lawsuits are pending in various state courts in Pennsylvania, California and New Jersey, while class action lawsuits have been filed in Canada. Johnson & Johnson has established an accrual with respect to the Invokana litigation. "Our firm is representing numerous individuals who suffered serious side effects allegedly related to Invokana, including diabetic ketoacidosis, heart attack and stroke, kidney injuries, and lower limb amputations. As we continue to be contacted by potential Invokana plaintiffs with similar claims, it is not at all surprising that the litigation involving this medication continues to grow at a significant rate," saysSandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate legal claims on behalf of Type 2 diabetes patients who were allegedly injured as result of Invokana. Approved by the U.S. Food & Drug Administration (FDA) in M Continue reading >>

Invokana Lawsuit

Invokana Lawsuit

The U.S. Food and Drug Administration has issued a new safety alert regarding a possible increase in the risk of leg or foot amputation after taking the antidiabetic medication, Invokana. Previous safety warnings were also issued about an increased risk of severe urinary tract infection and diabetic ketoacidosis which has required hospitalization and dialysis due to kidney failure. Invokana, a medication used to treat Type 2 diabetes, may have caused serious injury in some patients. Patients who have taken Invokana may have experienced leg, foot or toe amputation, kidney failure, heart attack or other events which were life-threatening or resulted in permanent injury. Many of these patients or their family members have filed an Invokana lawsuit against the manufacturer of Invokana, stating that the company failed to warn the public and the medical community about the potential risks of the medication. If you or a loved one required amputation, experienced kidney failure with dialysis, heart attack or other serious injuries after taking Invokana, you may be eligible for legal compensation. What is Invokana? Invokana (canagliflozin) is a newer type of anti-diabetic medication used to treat Type 2 diabetes. It is a member of the class “SGLT2 inhibitors” (sodium-glucose-co-transporter 2) medications that work to lower blood sugar by encouraging the body to release excess sugar into the urine. Normally, insulin is secreted by the body to help move sugar or glucose from the bloodstream into the cells where it can be used as energy. Type 2 diabetics are often resistant to insulin, causing the sugar to remain in the blood stream, unusable by the cells. This excess sugar is excreted into the urine but is reabsorbed by the kidneys. Over time, high blood sugar may cause perman Continue reading >>

Invokana Lawsuit

Invokana Lawsuit

The Food and Drug Administration has recently issued a Black Box warning about Invokana and the risk of amputation. Other safety concerns have been raised over serious side effects such as severe urinary tract infection, kidney failure and heart attack. If you or a loved one have been harmed after taking Invokana, you may be eligible to file an Invokana lawsuit. Should I talk to a lawyer about the experience I had with the drug Invokana? If you or a loved one used the type 2 diabetes medication Invokana, you might be eligible for financial compensation. Some Invokana users have required amputation of the leg, foot or toe after using the drug. Others have developed diabetic ketoacidosis or suffered other side effects such as severe kidney infection, heart attack or stroke after taking Invokana. Invokana (canagliflozin) is an SGLT2 inhibitor, which is a type of medication that works by lowering blood glucose levels. It does this by encouraging higher amounts of sugar to be released through urine. Though the medication does help control blood sugar levels, it triggers a number of other side effects, many of which are severe. Some Invokana users experienced cardiovascular issues including heart attacks and strokes, as well as diabetic ketoacidosis and kidney health issues. Final results from two clinical studies, CANVAS and CANVAS-R have shown that use of Invokana may double the risk for limb amputation and have prompted the FDA to release a black box warning about the risk. For some, the use of Invokana triggered side effects so severe they needed hospitalization. Others suffered permanent disability. In response to these devastating medical emergencies, many Invokana users have opted to take legal action against the makers of the drug. Both Janssen Pharmaceuticals and its Continue reading >>

The Invokana Lawsuit - Amputations, Ketoacidosis & Kidney Injuries

The Invokana Lawsuit - Amputations, Ketoacidosis & Kidney Injuries

The Invokana lawsuits claim the manufacturers of Invokana failed to warn patients and physicians of the increased risks of amputations, kidney failure and ketoacidosis. Our law firm is accepting clients who took Invokana and suffered any of the above injuries. We have been handling claims against pharmaceutical companies since 1955, and we are listed in Best Lawyers in America and The National Trial Lawyers Hall of Fame. Why are Invokana Lawsuits Being Filed Thousands of claims have been filed against Johnson & Johnson and Janssen Pharmaceuticals by individuals who have suffered injuries as a result of taking Invokana. The lawsuits are presently combined before a federal judge in New Jersey where all of the national discovery and evidence gathering is taking place. Invokana linked to amputations, kidney damage and ketoacidosis. Yet, the manufacturers failed to properly warn. In the court filings, lawyers argue the following: Invokana is defective and unreasonably dangerous. Johnson & Johnson was negligent in the manufacturing of the drug. The company failed to properly test the medication, and failed to warn of the increased risks of amputations, kidney failure and ketoacidosis. Johnson & Johnson concealed evidence of the dangers from the government and the public, and misrepresented the safety of the drug in its marketing material. The most serious potential side effects and risks caused by Invokana are amputations, kidney damage and ketoacidosis. Clinical trials have found that patients taking Invokana are twice as likely to suffer a leg or foot amputation as those taking a placebo. Toe amputations and those in the middle of the foot are most common. Individuals taking Invokana should be especially careful to look for signs of increased tenderness, sores, ulcers, and Continue reading >>

Invokana Lawsuit - Ketoacidosis & Amputation Side Effects

Invokana Lawsuit - Ketoacidosis & Amputation Side Effects

FDA warns: ketoacidosis, kidney & amputation risks Over 1,000 have already filed Invokana lawsuits Your case: do you qualify & how to choose a lawyer? The FDA has issued warnings for a number of side effects of Invokana that werent disclosed by the manufacturer, such as diabetic ketoacidosis, pancreatitis, kidney damage and an increased risk of leg, foot or toe amputation. Lawsuits alleging injury from the side effects of Invokana have been joined in a unique federal court and are scheduled to begin trials in 2018. Get the latest developments in these cases as well as news of possible settlements. Attorneys are still helping those affected by Invokana file claims. However, the time to take action is limited. Speak to a lawyer today to learn about your options and join the litigation. It costs nothing unless you win. The claims filed against Janssen Pharmaceuticals for Invokana injuries usually seek compensation for medical bills, lost wages, future expenses, pain and suffering. These can vary from less than $50,000 to more than $1 million in death cases. Since every case is unique, it is difficult to predict the value without a complete review of medical records and gathering facts from the injured party. For this reason, it is recommended that patients who suffered complications while taking Invokana speak with a lawyer to determine if they qualify for a case and what it may be worth. Fortunately, it costs nothing to file a claim, and the injured patient is only responsible for attorneys fees and costs if they receive an award in their case. What Is Involved In Filing A Claim? How Long Will It Take Me? Filing an Invokana lawsuit is simple. After a short, free telephone conference to see if your case qualifies, your lawyer will collect medical records to begin building Continue reading >>

Invokana Lawsuit: Diabetic Ketoacidosis

Invokana Lawsuit: Diabetic Ketoacidosis

Basis of Invokana Lawsuit The Invokana lawsuit is against the drug manufacturer for failure to warn about the risk of Invokana causing diabetic ketoacidosis (DKA). The Invokana lawsuits allege that Johnson & Johnson and their subsidiary Janssen Pharmaceuticals, Inc. failed to warn both prescribing doctors and patients of the potential risk of Invokana causing diabetic ketoacidosis. If identified and treated properly, diabetic ketoacidosis can usually be reversed quickly and easily. Unfortunately, most patients that have experience Invokana-induced diabetic ketoacidosis are not being properly diagnosed and treated. Failure to treat diabetic ketoacidosis in a timely fashion can result in extended hospitalization, organ damage, and even death. Our Invokana lawyers believe that if Johnson & Johnson would have provided adequate warnings on Invokana, then many physicians would not have prescribed Invokana, patients would not have consented to taking Invokana, and the signs and symptoms for Invokana-induced diabetic ketoacidosis would have been monitored closer. All Invokana lawsuits filed in Federal court have been consolidated into a Multi-District Litigation (MDL) in the United States District Court for the District of New Jersey under Judge Brian R. Martinotti. There Invokana lawsuits consolidated in New Jersey state court, where Johnson & Johnson is located. Invokana remains on the market in the United States, even as the lawsuits continue to pile up. About Invokana Invokana, also known by its chemical name canagliflozin, came to the market in the United States in 2013. Invokana was approved by the United States Food and Drug Administration for the treatment of adults with Type 2 diabetes. Invokana was the first of a new class of medications called sodium glucose co-trans Continue reading >>

New Invokana Ketoacidosis Lawsuit Joins Hundreds In Invokana Mdl

New Invokana Ketoacidosis Lawsuit Joins Hundreds In Invokana Mdl

New Invokana Ketoacidosis Lawsuit Joins Hundreds in Invokana MDL A man has filed an Invokana ketoacidosis lawsuit within the larger multidistrict litigation taking place in New Jersey federal court. As of the last update, the plaintiffs lawsuit joins approximately 444 others with similar allegations surrounding the drug. Plaintiff William B. says he began taking Invokana in May 2015 to treat his type-2 diabetes. Approximately two months later, William says, he was diagnosed with diabetic ketoacidosis, the Invokana ketoacidosis lawsuit states. He was then required to be hospitalized on a number of occasions and required substantial medical treatment for his injuries. Invokana (canagliflozin) was approved by the FDA in March 2013 to treat patients with type-2 diabetes. It belongs to a class of medications known as sodium-glucose co-transporter 2 inhibitors. Several other drugsare included in this class. These medications work by inhibiting the reabsorption of renal glucose, which then getsexcreted in the urine rather than being reabsorbed into the body. While this is effective in lowering blood sugar levels, it also tends to put a great deal of stress on the kidneys of patients who are already at risk of kidney disease because of their type-2 diabetes. Anumber of patients taking Invokana have developed a serious condition known as ketoacidosis. This condition develops when a persons body burns a large proportion of fat for energy instead of glucose. Along with the breakdown of fats, ketones are introduced into the bloodstream, and these are very acidic. Having acidic blood can be very damaging. The pH of a persons blood must remain at an appropriate pH level, and anything that makes the blood too alkaline or to acidic is harmful. When ketones build up in the body, ketoac Continue reading >>

Invokana & Sglt2 Lawsuits - Settlements, Status & Claims

Invokana & Sglt2 Lawsuits - Settlements, Status & Claims

Hundreds of lawsuits have been filed against the manufacturers of Invokana and other SGLT2 inhibitor drugs. Cases are being brought by people who took the drugs and suffered various injuries, including kidney damage and cardiovascular issues. The lawsuits are in their early stages and have not gone to trial or been the subject of large settlements yet. People who say they suffered serious injuries after taking Invokana and other SGLT2 inhibitor diabetes drugs are suing the manufacturers in the U.S. and Canada seeking compensation for what happened to them. The lawsuits are the subject of two federal Multidistrict Litigations, and trials have not yet begun. About SGLT2 Drug Lawsuits are in their early stages and have not yet proceeded to trial or been part of any large settlements. But the cases involving about 800 plaintiffs who say the drugs caused injuries are proceeding on several fronts: The U.S. Judicial Panel on Multidistrict Litigation ordered Invokana cases consolidated in multidistrict litigation (MDL) No. 2750 in New Jersey before Judge Brian R. Martinotti. As of October 16, 2017, over 740 cases are involved in the Invokana MDL. Clarkson S. Fisher Federal Courthouse, site of the Invokana New Jersey MDL According to Johnson & Johnson, there are also federal lawsuits over Invokana pending in federal court in California and Missouri. There are also cases in state courts in Pennsylvania, California and New Jersey. U.S. District Judge Lorna G. Schofield is overseeing a Farxiga MDL in the Southern District of New York. As of October 16, 2017, there were 44 cases pending in the Farxiga MDL. Bellwether trials help parties get an idea how the remaining cases may play out. Bellwether trials involve cases selected by the parties to go to trial first in MDLs and other ma Continue reading >>

Invokana (sglt2 Inhibitor) Lawsuits For Ketoacidosis, Bone Fractures, And Kidney Failure

Invokana (sglt2 Inhibitor) Lawsuits For Ketoacidosis, Bone Fractures, And Kidney Failure

Invokana (SGLT2 Inhibitor) Lawsuits for Ketoacidosis, Bone Fractures, and Kidney Failure The Lopez McHugh pharmaceutical attorneys are investigating Invokana ketoacidosis lawsuits, as well as other SGLT2 inhibitor lawsuits. If you or someone you know were diagnosed with diabetic ketoacidosis, kidney failure, severe infection (genital mycotic infections), or a fracture while taking Invokana, find out if you have a claim by submitting the form on the right-hand side, or calling us, at 877-703-7070. Joshua Mankoff, Esquire is heading the Lopez McHugh team on this case, and has been appointed as a co-chair of the American Association of Justice SGLT2 litigation group, to take a leadership role in coordinating Invokana cases across the country. SGLT2 inhibitors are prescription medications that are supposed to help lower blood sugar in adults with type 2 diabetes. SGLT2 is short for sodium-glucose co-transporter-2. These medications are approved by the Food & Drug Administration to lower blood sugar by causing the kidneys to remove sugar from the body through the urine. The currently available SGLT2 inhibitors include: Glyxambi (empagliflozin and linagliptin). According to FDA Adverse Event Reports, use of SGLT2 inhibitors for diabetes has been associated with patients developing diabetic ketoacidosis, or too much acid in the blood. The FDA issued a Drug Safety Communication warning diabetes patients using SGLT2 inhibitors to watch for signs of ketoacidosis such as difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness. The warning was issued after 20 cases of ketoacidosis were identified in the FDAs Database of Adverse Events related to the use of diabetes medications known as SGLT2 inhibitors such as Invokana and Invokamet. An Continue reading >>

Invokana And Ketoacidosis Lawsuit

Invokana And Ketoacidosis Lawsuit

Large pharmaceutical companies seem to take any opportunity available these days to rush their products to market without a second thought to the safety of those who rely on their medications. The latest medication to fall under the scrutiny of the FDA is Invokana, which was the first medication created to help type-2 diabetics control their blood sugar by employing the kidneys to remove glucose through the urine. The Chicago Invokana attorneys of Rosenfeld Injury Lawyers LLC are currently representing victims following the establishment of a link between Invokana and ketoacidosis, which is a condition that can cause patients to fall into a coma or die from complications. If you or a family member suffered an injury, such as ketoacidosis after taking Invokana, we invite you to contact our office for a free case review. Rosenfeld Injury Lawyers LLC is a leader in pharmaceutical litigation and is committed to providing you with the legal assistance you need to get the maximum recovery for your case. Our attorneys are based in Chicago and are presently reviewing Invokana complication cases across the country. Contact our office today for a free case review and a discussion of the status of current Invokana lawsuits. Type-2 diabetes is a disorder in which the body is unable to regulate blood sugar levels due to lowered insulin output by the pancreas and increased insulin resistance by the bodys cells. Elevated blood sugar levels cause sufferers to experience symptoms that include fatigue, lightheadedness, difficulty concentrate, increased risk of infection and difficulty healing from wounds. Invokana was designed to lower blood sugar by making the kidneys eliminate excess glucose from the blood stream by passing it through the urine. Invokana and Invokamet were the first t Continue reading >>

More in ketosis